TQB2450 Injection Combined With Chemotherapy Followed by Sequential Combination With Anlotinib Hydrochloride Capsule for First-line Treatment of Advanced Squamous Non-small Cell Lung Cancer.
Clinical trial NCT05718167 · UNKNOWN
Trial details
- NCT number
- NCT05718167
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-01
- Primary completion
- 2024-10-01
- Enrollment
- 570
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.